There is a critical need for sensitive, highly specific immunoassays of clinical samples using minimal sample volume. Advances in microfluidic systems enable the sensitive quantitation of proteins in a small sample volume by using parallel detection systems. In contrast to multiplexing, this parallel approach prevents cross-reactivities of detection antibodies and negative effects on sensitivity of the assays. This live webinar brings together a panel of experts to discuss how they are validating immunoassays for clinical use.
Topics to be covered:
Dr. Marianne Manchester
Head, Immunoassay and Metabolites Lab
Roche Innovation Center Basel
Dr. Martina Thier
Head, Immunoassay Lab
Roche Innovation Center Basel
Isabelle Wey
Technician, Immunoassay Lab
Roche Innovation Center Basel
